Ckd Bio (063160) — Capital Reinvestment Ratio
Latest as of March 2026:
4.74x
Ckd Bio (063160) has a Capital Reinvestment Ratio of 4.74x as of March 2026, meaning it reinvests 5% of its operating cash flow (₩771.88 Million) in capital expenditures (₩3.66 Billion). See cash generation quality of Ckd Bio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
4.74x
Capex / Operating Cash Flow
Operating Cash Flow
₩771.88 Million
KRW
Capital Expenditures
₩3.66 Billion
KRW
Data as of
Mar 2026
Most recent filing
Ckd Bio Capital Reinvestment Ratio (2008–2024)
This chart tracks Ckd Bio's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Ckd Bio (2008–2024)
Year-by-year Capital Reinvestment Ratio for Ckd Bio from 2008 to 2024. For live market cap and broader valuation context, see Ckd Bio market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.31x | ₩14.03 Billion | ₩4.28 Billion | ▼ -97.6% |
| 2020 | 12.78x | ₩4.82 Billion | ₩61.66 Billion | ▲ +359.0% |
| 2019 | 2.78x | ₩16.99 Billion | ₩47.31 Billion | ▲ +163.9% |
| 2018 | 1.06x | ₩15.54 Billion | ₩16.40 Billion | ▲ +123.1% |
| 2017 | 0.47x | ₩20.45 Billion | ₩9.67 Billion | ▼ -31.8% |
| 2016 | 0.69x | ₩15.50 Billion | ₩10.76 Billion | ▼ -16.5% |
| 2015 | 0.83x | ₩14.34 Billion | ₩11.91 Billion | ▲ +225.1% |
| 2014 | 0.26x | ₩11.22 Billion | ₩2.87 Billion | ▼ -31.9% |
| 2013 | 0.38x | ₩10.92 Billion | ₩4.10 Billion | ▲ +56.7% |
| 2012 | 0.24x | ₩22.90 Billion | ₩5.48 Billion | ▼ -86.0% |
| 2011 | 1.70x | ₩12.96 Billion | ₩22.09 Billion | ▲ +106.2% |
| 2010 | 0.83x | ₩23.89 Billion | ₩19.74 Billion | ▲ +62.3% |
| 2009 | 0.51x | ₩26.57 Billion | ₩13.53 Billion | ▲ +56.8% |
| 2008 | 0.32x | ₩10.69 Billion | ₩3.47 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow